الفهرس | Only 14 pages are availabe for public view |
Abstract Over the last 50 years type 2 diabetes mellitus (T2DM) is growing rapidly. Today diabetes is present in over 235 million individualsworldwide. Over the next few decades a remarkable increase in diabetes is projected. Estimate of the global prevalence of diabetes in the year 2010 and the projections for 2030 surprisingly indicate that, over 439 million people are projected to suffer from this condition and that Egypt will be ranked as the 10th country worldwide which has the highest number of people with diabetes, making it one of the most serious diseases of humankind. Identifying the etiology and the early detection oftype 2 diabetes are keys to prevention. So there is a great need for early detection tool or a predictor to determine the risky factors for individuals to develop T2DM. So, with the administration of proper drugs and applying the individuals to controlled diet or physical intervention, the development of disease or its complication can be prevented. The study of early predictors in human is difficultbecause it require large cross-sectional prospective study. So using animal modelsof T2DM is of great importance to illustrate various types of etiological and pathogenic mechanisms that could also operate in humans. Among these models, diabetes induced in rats by neonatal streptozotocin (STZ) administration (so-called “n-STZ models”). This model has many advantages over other models of diabetes and is considered to be one of the suitable experimental animal models of T2DM. This study focused on the early changes of circulating three adipocytokines during the course of T2DM induction due to the documented role of adipose tissues in the pathogenesis of T2DM. This study interested in investigating the role of three adipocytokines, namely; tumor necrosis factor-alpha (TNF-α), visfatin and vaspin,as an early markers or predictors during the experimental induction of T2DM using n-STZ rat model. Rat neonates were injected intraperitoneally with STZ (100mg/Kg) at the 5 th day of birth (diabetic group). The control neonates were injected with saline at the 5 th day of birth (control group). All rats will be followed up for 5 months and a blood sample will bewithdrawn from each rat every one month. The serum will be used for the determinationof the study parameters; fasting blood sugar, insulin, HOMA-IR, lipid profile, TNF-α, vaspin and visfatin. The results of this study indicated that by 3 rd month of age, n-STZ rats show higher weight and FBS and lower insulin level than controlrats. By age 4 month and thereafter mild hyperglycemia was developed (130–180 mg/dL) and insulin deficiency was evidenced together with insulin resistance as indicated by increased HOMA-IR in n-STZ rats compared to control rats. The defect in glucose homeostasis in n-STZ rats is associated with derangements in the lipid metabolism as indicated by age-dependent elevated levels of triglycerides and total and LDL-cholesterol and decreased level of HDL-cholesterol. The patterns of changes of the adipocytokines are interesting. TNF-α show age- dependent increase in control and diabetic rats. The n-STZ diabetic rat shows a significantly higher TNF-alpha level from the second month of age compared to control rats in males while in females at the third month of age. The correlation studies indicated that TNF-α is positively correlated with weight, FBS, insulin and HOMA-IR in n-STZ diabetic rat model males and females. The results of vaspin show an interesting pattern of changes. First, it shows gender difference as female rats (normal or diabetic) havehigher level than male rats. Second, male rats of the diabetic group show a significant higher level of vaspin from the second month of age and show biphasic change; during earlylive it show a gradual increase with age from the first month of age until the fourth month after which it begin to decrease (coincidence with hyperglycemia). Female rats of the diabetic group show abnormal high level of vaspin only after the 4 th month of age. As vaspin, visfatin show gender difference; female rats have higher level than male rats (normal and diabetic). There is no significantchange observed in n-STZ rats from control until 4 th month after which the visfatin level becomes significantly elevated. However, the individual results of TNF-α, vaspin and visfatin have little value as independent predictor for T2DM, combinations of their values as ratios may produce more clear results. While TNF-α/vaspin and TNF-α/visfatin ration didn’t show significant differences between normal rats and n-STZ diabetic rat in model male or female, visfatin/vaspin ratio show great decrease in the male diabetic model during early development of the diseases while after 5 th month of age and the incidence of hyperglycemia the ratio show no significant change. When we use ratio of the visfatin to insulin the pattern obtained show significantly increased values as early as the first month of agein male and female n-STZ rats that could be used for predicting the development of T2DM. Also, the ratio of vaspin to insulin could be used especially in males while in females its value become significant only from the 3 rd month of age. from the results of the present study we can conclude that: 1- TNF-α show significant elevation in the n-STZ rat model of T2DM from 2 nd month of age in male and from 3 rd month in female 2- Vaspin show gender difference between male and female. In male n-STZ rat model show biphasic change; during early live it show a gradual increase with age from the first month of age until the fourth month after which it begin to decrease (coincidence with hyperglycemia) 3- Visfatin show gender difference. In n-STZ rat model of T2DM visfatin show no significant change until 4 th month of age 4- The individual results of TNF-α, vaspin and visfatin have little value as independent predictor for T2DM 5- Assessment of the adipocytokines vaspin and visfatin together with insulin and calculating visfatin/vaspin and visfatin/insulin ratio may provide useful information about the prediction for the development of T2DM. |